Stock Events

Stock Events

4D Molecular Therapeutics Common Stock (FDMT) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.81

-0.62

-0.43

-0.24

Details

Expected EPS

-0.74089

Actual EPS

-0.66

Surprise EPS

0.08

Surprise Percent

+10.92%

Description

4D Molecular Therapeutics Common Stock (FDMT) has reported earnings of -0.66 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.